DSpace Repository

Cervical Dysplasia, Infection, and Phylogeny of Human Papillomavirus in HIV-Infected and HIV-Uninfected Women at a Reproductive Health Clinic in Nairobi, Kenya

Show simple item record

dc.contributor.author Omire, Agnes
dc.contributor.author Budambula, Nancy
dc.contributor.author Kirumbi, Leah
dc.contributor.author Langat, Hillary
dc.contributor.author Kerosi, Danvas
dc.contributor.author Ochieng, Washingtone
dc.contributor.author Lwembe, Raphael
dc.date.accessioned 2020-06-24T09:26:11Z
dc.date.available 2020-06-24T09:26:11Z
dc.date.issued 2020-06
dc.identifier.citation BioMed Research International Volume 2020, Article ID 4945608, 10 pages en_US
dc.identifier.uri https://doi.org/10.1155/2020/4945608
dc.identifier.uri http://repository.embuni.ac.ke/handle/embuni/2417
dc.description.abstract High risk human Papillomavirus (HPV) infections ultimately cause cervical cancer. Human Immunodefi ciency Virus (HIV) infected women often present with multiple high-risk HPV infections and are thus at a higher risk of developing cervical cancer. However, information on the circulating high-risk HPV genotypes in Kenya in both HIV-infected and HIV-uninfected women is still scanty. This study is aimed at determining the phylogeny and the HPV genotypes in women with respect to their HIV status and at correlating this with cytology results. This study was carried out among women attending the Reproductive Health Clinic at Kenyatta National Hospital, a referral hospital in Nairobi, Kenya. A cross-sectional study recruited a total of 217 women aged 18 to 50 years. Paired blood and cervical samples were obtained from consenting participants. Blood was used for serological HIV screening while cervical smears were used for cytology followed by HPV DNA extraction, HPV DNA PCR amplifi cation, and phylogenetic analysis. Out of 217 participants, 29 (13.4%) were HIV seropositive, while 68 (31.3%) were positive for HPV DNA. Eight (3.7%) of the participants had abnormal cervical cytology. High-risk HPV 16 was the most prevalent followed by HPV 81, 73, 35, and 52. One participant had cervical cancer, was HIV infected, and had multiple highrisk infections with HPV 26, 35, and 58. HPV 16, 6, and 81 had two variants each. HPV 16 in this study clustered with HPV from Iran and Africa. This study shows the circulation of other HPV 35, 52, 73, 81, 31, 51, 45, 58, and 26 in the Kenyan population that play important roles in cancer etiology but are not included in the HPV vaccine. Data from this study could inform vaccination strategies. Additionally, this data will be useful in future epidemiological studies of HPV in Nairobi as the introduction or development of new variants can be detected. en_US
dc.language.iso en en_US
dc.publisher Hindawi en_US
dc.title Cervical Dysplasia, Infection, and Phylogeny of Human Papillomavirus in HIV-Infected and HIV-Uninfected Women at a Reproductive Health Clinic in Nairobi, Kenya en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account